Record Quarterly Revenue
Q2 revenue was a record $1.69 billion, up 7% sequentially and 17% year-over-year (pro forma: +9% sequential, +22% YoY excluding the divested aerospace & defense business). Guidance for Q3 revenue: $1.7B–$1.84B.
Very Strong Data Center & Communications Growth
Data center & communications now account for >70% of revenue. Q2 segment revenue rose 11% sequentially and 34% YoY; data center revenue specifically grew 14% sequentially and 36% YoY, driven by 800G and 1.6T transceivers and strong bookings.
Significant Bookings and Visibility
Data center bookings produced a book-to-bill ratio exceeding 4x; many customer orders booked into calendar 2027 with multi-year forecasts extending into 2028, providing strong revenue visibility.
Gross Margin and EPS Expansion
Q2 non-GAAP gross margin was 39.0%, up 24 basis points sequentially and 77 basis points YoY. Non-GAAP EPS was $1.29, up 11% sequentially and 35% YoY. Non-GAAP operating margin rose to 19.9% (from 19.5% prior quarter).
Rapid Six-Inch Indium Phosphide Ramp
On track to double internal indium phosphide capacity by calendar Q4; current wafer starts are ~80% of that doubling target. Six-inch wafers produce >4x chips versus three-inch at <50% cost, with six-inch yields exceeding three-inch yields — expected to be a material gross-margin driver.
CPO and OCS Design Wins and Backlog
Secured a large CPO purchase order from a leading AI data center customer (initial revenue expected late calendar year, meaningful contribution next year). OCS backlog grew sequentially, with >10 customer engagements and shipments/backlog across 64x64 and 320x320 system sizes; OCS revenue expected to grow sequentially and ramp through the year.
Communications Market Strength and Design Wins
Communications revenue grew 9% sequentially and 44% YoY, driven by DCI and telecom recovery. Notable multiyear design win with a leading DCI OEM for an uncooled three-pin micropump solution.
Balance Sheet and Portfolio Optimization
Debt leverage ratio improved to 1.7x (from 2.3x YoY). Completed sale of Munich product division (avg quarterly revenue ~$25M, lower-margin) — sale expected to be immediately accretive to gross margin and EPS and reduces ~425 employees. Exited 10 sites this quarter (33 sites exited/sold over ~6 quarters).
Investing to Meet Demand (CapEx and Capacity Expansion)
Q2 capital expenditures were $154M (vs $104M prior quarter). Investing in expanded assembly/test capacity in Malaysia and Vietnam and additional indium phosphide production sites (Sherman, TX and Yarfala, Sweden); CapEx expected to increase sequentially to support demand.